Company Filing History:
Years Active: 2024
Title: The Innovations of Julien Korac
Introduction
Julien Korac is a notable inventor based in Gosselies, Belgium. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific biological pathways. His work is particularly relevant in the context of treating proliferative diseases, including various forms of cancer.
Latest Patents
Julien Korac holds a patent for "Piperidine derivatives as METTL3 inhibitors." This patent describes compounds of formula (I), or the pharmaceutically acceptable salts and/or the solvates thereof, which are useful as inhibitors of METTL3 (N6-adenosine-methyltransferase subunit) activity. These compounds are particularly promising for the treatment of proliferative diseases such as cancers. He has 1 patent to his name.
Career Highlights
Julien Korac is currently associated with Epics Therapeutics, a company focused on innovative therapeutic solutions. His work at Epics Therapeutics has positioned him as a key player in the development of new treatments that could potentially change the landscape of cancer therapy.
Collaborations
Throughout his career, Julien has collaborated with several talented individuals, including Guillaume Dutheuil and Graeme Lovat Fraser. These collaborations have enriched his research and contributed to the advancement of his innovative projects.
Conclusion
Julien Korac's contributions to the field of medicinal chemistry and his innovative patent for METTL3 inhibitors highlight his role as a significant inventor in the fight against cancer. His ongoing work at Epics Therapeutics continues to pave the way for new therapeutic options.